Cite
HARVARD Citation
Paukner, S. et al. (2022). Pooled microbiological findings and efficacy outcomes by pathogen in adults with community-acquired bacterial pneumonia from the Lefamulin Evaluation Against Pneumonia (LEAP) 1 and LEAP 2 phase 3 trials of lefamulin versus moxifloxacin. Journal of global antimicrobial resistance. pp. 434-443. [Online].